Published 2 days ago • loading... • Updated 2 days ago

Abbott Laboratories' (ABT) Overweight Rating Reaffirmed at Piper Sandler

Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price target on shares of Abbott Laboratories in a report on Monday.

Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price target on shares of Abbott Laboratories in a report on Monday.

2 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated1 day agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news 2 days ago on Monday, June 22, 2026.

Sources are mostly out of (0)